# Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

> **NCT00566254** · PHASE3 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 207 (actual)

## Conditions studied

- Epilepsy; Paediatric Partial Onset Seizures

## Interventions

- **DRUG:** Zonisamide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00566254
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 207 (ACTUAL)
- **Last updated:** 2013-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00566254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00566254, "Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00566254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*